Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search


Pharmac Removes Cap On Multiple Sclerosis Drug

Health Minister Annette King has welcomed Pharmac’s decision to remove the funding cap on beta interferon, allowing more New Zealanders with multiple sclerosis access to the treatment.

The decision will initially see a further 50 patients given subsidised beta interferon, with the prospect of more following if they meet the criteria for accessing the drug.

Beta interferon is currently subsidised for 180 patients under a funding cap, with further patients meeting the entry criteria put on a waiting list. The funding cap has now been removed and fully subsidised beta interferon made available without delay to all patients who meet the entry criteria published in the Pharmaceutical Schedule.

Ms King said multiple sclerosis was a terrible disease, for which there was no cure and only limited treatment options. “Beta interferon has been shown to provide benefits to some MS patients so it is pleasing that Pharmac is able to make this change and offer the drug to more patients.”

Pharmac chief executive Wayne McNee the decision followed a recommendation from the expert committee that was set up to consider the subsidised access to the beta interferon waiting list. All patients who meet the entry criteria will now have immediate subsidised access to beta interferon.

Multiple sclerosis patients are given access to subsidised beta interferon according to a set of entry and exit criteria developed by expert neurologists.

“Beta interferon is a costly drug and one that continues to be the subject of international scrutiny, so we have to ensure that it is targeted at people who will benefit from it,” he said.

Mr McNee said that when a specialist committee such as MSTAC (Multiple Sclerosis Treatment Advisory Committee) made a recommendation, it did so considering only clinical issues for the condition it was looking at. Wider health sector issues were then considered by Pharmac before any recommendation could be implemented.

The removal of the cap for beta interferon has been made possible through savings in other areas of the pharmaceutical budget. The change is expected to cost up to an additional $3 million a year.


© Scoop Media

Parliament Headlines | Politics Headlines | Regional Headlines

Scoop 3.0: How You Can Help Scoop’s Evolution

Entering into its third decade of operation, the Scoop news ecosystem is set to undergo another phase of transformation and evolution.

We have big plans for 2018 as we look to expand our public interest journalism coverage, upgrade our publishing infrastructure and offer even more valuable business tools to commercial users of Scoop. More>>


Speaking Of Transport: Public Engagement On Wellington Scenarios

“Our work on possible solutions for Wellington’s transport future is ongoing, but has progressed to the stage where we’re ready to share our ideas with the public and seek their feedback to help guide our next steps...” More>>


Parental Leave: National's Time-Sharing Change Fails

National has proposed a change to the Parental Leave and Employment Protection Amendment Bill that would allow both parents to take paid parental leave at the same time, if that is what suits them best. More>>


Train Free Thursday: Workers Strike To Defend Terms Of Employment

"They signed up to these conditions a year ago when they got the contract for Wellington's rail services. Now they're trying to increase profits by squeezing frontline workers." More>>


Seclusion: Ombudsman Emphasises Importance Of Monitoring

Disability Rights Commissioner Paula Tesoriero says that while there have been changes to the Education (Update) Amendment Act 2017 to prohibit the use of seclusion, the report is an important reminder of the importance of regular monitoring of schools. More>>


United Future History: "All Good Things Must End"

'We’re extremely proud of what we’ve achieved over the past 15 years, working alongside the government of the day, both National and Labour.' Mr Light told members on Monday. More>>

Gordon Campbell: On The TPP Outcome, And The Hobbit Law

Somehow the Trans Pacific Partnership trade deal has come lurching back from the dead – and as predicted in this column last week, the member countries gathered in Vietnam have announced a deal in broad principle, shunted aside until a later date the stuff on which they don’t agree, and declared victory. More>>

Agreeing To Differ: Greens Maintain Opposition To TPPA
“The Green Party has long opposed the TPPA. The new proposed deal, which came out of the weekend’s talks, still contains key ISDS concessions to corporations that put our democracy at risk, so our position remains the same,” said Green Party trade spokesperson Golriz Ghahraman. More>>


Monitoring Report: A New Chapter For Children’s Rights In New Zealand?

The Children’s Commissioner is calling on the country to embrace children’s rights to ensure their overall well-being. More>>





Featured InfoPages

Opening the Election